Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
Science Advances|October 22, 2025
Cluster nanoarchitecture and structural diversity of PIEZO1 at rest and during activation in intact cellsClement Verkest, Lucas Roettger, Nadja Zeitzschel, et al.
Frontiers in Endocrinology|November 29, 2023
Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitusRobin Hilder, Karen Tsai, Zoe Quandt, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 8, 2021
COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort StudyNikhita Kathuria-Prakash, Tina Mosaferi, Mindy Xie, et al.
Virology Journal|February 17, 2009
Gene expression in primate liver during viral hemorrhagic feverMahmoud Djavani, Oswald R Crasta, Yan Zhang, et al.
Thyroid : Official Journal of the American Thyroid Association|February 24, 2022
Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's ThyroiditisTina Mosaferi, Karen Tsai, Samantha Sovich, et al.
Head & Neck Oncology|February 24, 2010
Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1Daniel J Liebertz, Melissa G Lechner, Rizwan Masood, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2018
Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal CancersMelissa G Lechner, Chirag M Vyas, Ole-Petter R Hamnvik, et al.
Thyroid : Official Journal of the American Thyroid Association|April 14, 2018
Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer PatientsMelissa G Lechner, Chirag M Vyas, Ole-Petter R Hamnvik, et al.
Pageof 20